Affiliation:
1. Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Abstract
: Polycystic Ovary Syndrome (PCOS) is an endocrine disorder prevalent in women of reproductive age group. The intricate nature of PCOS development is highlighted by fluctuations in various sex hormones, such as luteinizing hormone(LH), follicle-stimulating hormone and prolactin. This study aims to assess the lipid profile levels, vital metals and sex hormones in the serum of patients with PCOS and contrast these findings with normal controls.The study analyzed health metrics between 57 women with PCOS and 57 normal controls. The lipid profile was assessed using Beckman Coulter AU480. Sex hormones were estimated using Roche Diagnostics Cobas 6000. Inductively coupled plasma mass spectrometry (ICPMS) was used to measure the essential trace metals, including magnesium (Mg), copper (Cu) Selenium (Se) and zinc (Zn).: The PCOS patients exhibited significantly elevated levels of LH (9.52 vs 3.48, p<0.0001), FSH (9.91 vs. 6.12, p<0.0001) and prolactin (24.71 vs. 16.41, p=0.03) mIU/ml. The correlation study showed a significant positive correlation between AMH and Se levels (R=0.27, p=0.045) and between LH and HDL (R=0.76, p=0.030).: In patients with PCOS, LH, FSH, and prolactin levels were found to be increased. A correlation was observed between Se and AMH, and a relationship was noted between LH and HDL. Selenium appears to have a significant influence on the ovarian reserve.
Publisher
IP Innovative Publication Pvt Ltd
Reference22 articles.
1. Yau TT, Ng NY, Cheung LP, Ma RC, Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences.Hong Kong Med J 2017;23(6):622-34
2. Oncul M, Ozcivit IB, Basibuyuk Z, Cebi C, Sahmay S, Anti-Müllerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism.Eur J Obstet Gynecol Reprod Biol 2022;273:54-8
3. Peluso C, Fonseca FL, Rodart IF, Cavalcanti V, Gastaldo G, Christofolini DM, AMH: An ovarian reserve biomarker in assisted reproduction.Clin Chim Acta 2014;437:175-82
4. Arabzadeh S, Hossein G, Rashidi BH, Hosseini MA, Zeraati H, Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome.Ann Saudi Med 2010;30(6):442-7
5. Broer SL, Broekmans FJ, Laven JS, Fauser BCJM, Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.Hum Reprod Update 2014;20(5):688-701